Global Value Equities EUR Acc

Basic equities

Key Information

  • ISIN

    DK0060647600

  • Inception

    21.09.2015

  • Return Profile

    Accumulated

  • Dividend

  • Risk Class

    5

  • Share Class Assets (m)

    22 EUR

  • ÅOP (Costs)

    2 %

  • Indirect Trade Cost

    0.05 %

  •  
  • KIID

  • Fund Facts

  • Prospectus

Show More

Profile

Investment profile
The fund is actively managed and pursues an equal weight strategy and a value strategy. The strategy basically has two aims. Firstly, investments are made in shares traded at low prices, ie value shares. Secondly, all portfolio shares carry equal weight, which means that most of the investors’ assets are invested in small and medium-size shares. We pursue an equal weight strategy and a value strategy because in a historical context inexpensive and small shares have proved to outperform the share market over time. The portfolio composition aims to reduce regional risk and sector risk relative to the fund’s benchmark.


The typical investor
The typical investor has an investment horizon of at least 3 years and is looking for a high degree of diversification across countries, sectors and companies as a good long-term investment opportunity. Investors are expected to know that risk factors, see “Risk factors” below, may at times lead to significant price fluctuations within the fund.

Benchmark
The objective is to obtain a return that equals or outperforms returns in global equity markets over a three-year period while observing the fund’s risk limits.

The fund invests globally in shares. Investments are diversified across different countries and industries. The fund’s largest investments are in USA and Europe. The fund pursues an equal weight value strategy. The idea behind equal weight is that all equity investments represent roughly the same share in the fund. For instance if the fund has invested in 100 shares, each share will constitute around 1.0% of the fund. When investing according to a value strategy, we select companies that are inexpensively priced based on a number of financial ratios relative to the share price of the companies.

The fund’s benchmark is MSCI All Country World Index, including net dividends, unhedged to EUR.

Returns

Date 14/12/18 12:05

Today's Return: -0.94%

Return Nov.: +1.05%

Return YtD: -3.21%

NAV per. 14/12/18 12:05

Today's Returns -0.94 %
Return year to date, % -3.21 %
Redemption 14.63
Subscription 14.63
NAV 14.63
Total Assets (m) 22 EUR

Returns - Last Update 01/12/18

Return year to date, % 1.67 %
1 Year 2.73%
3 Years 18.37%
5 Years 54.79%
7 Years 107.75%
10 Years 200.24%

NAV development

Export graph-data

Include:

Return & Dividend

YearReturnsDividendIncome on equityCapital incomeTaxfreeNAV per unit (End Year)
20174.22%-0.000.000.0015.11
201617.70%-0.000.000.0014.50
20156.75%-0.000.000.0012.32
201416.52%-0.000.000.0011.54
201315.92%-0.000.000.009.90
201212.30%-0.000.000.008.54
2011-4.85%-0.000.000.007.61
201025.04%-0.000.000.008.00
200930.23%-0.000.000.006.39
2008-42.50%-0.000.000.004.91
2007-3.37%-0.000.000.008.54
20065.64%-0.000.000.008.84
200519.54%-0.000.000.000.00
20043.15%-0.000.000.000.00
200311.88%-0.000.000.000.00
2002-35.77%-0.000.000.000.00
2001-16.14%-0.000.000.000.00
2000-7.38%-0.000.000.000.00
199952.38%-0.000.000.000.00
199810.56%-0.000.000.000.00
199716.14%-0.000.000.000.00
199616.48%-0.000.000.000.00
19957.45%-0.000.000.000.00
1994-8.03%-0.000.000.000.00
Show More

Latest trends

Global Value Equities EUR AccReturn NovemberReturn YtD
Latest trend1.05%1.67%
Return benchmark1.53%3.35%

Development in NAV

Expectations of return

Fund's Holdings

Fund Holdings

Top 10 HoldingsIndustryCountryProportion
Express ScriptsHealth Care ServicesUSA0.77%
Lilly EliPharmaceuticalsUSA0.75%
Automatic Data ProcessingData Processing & Outsourced ServicesUSA0.70%
WalgreenDrug RetailUSA0.69%
UnitedhealthManaged Health CareUSA0.68%
CignaManaged Health CareUSA0.68%
CGI GroupIT Consulting & Other ServicesCanada0.67%
PfizerPharmaceuticalsUSA0.67%
NWS HoldingsIndustrial ConglomeratesHong Kong0.66%
Biogen IdecBiotechnologyUSA0.66%
Fund Holdings: 191
Show all

Distribution by country

Distribution by industry

IndustryProportionChanges in percentage points
Financials16.91%-0.82%
Information Technology16.61%1.13%
Health Care11.80%1.38%
Industrials11.15%0.92%
Consumer Discretionary10.45%-1.35%
Consumer Staples7.83%-0.63%
Energy7.16%0.61%
Materials5.61%0.65%
Utilities3.22%1.29%
Other9.26%-1.38%

Distribution by country

CountryProportionChanges in percentage points
USA49.71%4.97%
Canada7.27%-1.83%
Japan6.97%0.14%
Great Britain6.60%1.43%
France3.99%-2.16%
China3.05%-0.34%
Australia2.01%0.13%
South Korea1.79%0.06%
Switzerland1.77%-0.36%
Other16.84%-0.24%

Risk

Lower risk

Higher risk

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Potentially lower rewards

Potentially higher rewards

Risk Scale

Placement of the fund on the scale is determined by the fluctuations of the funds NAV over the past five years.

Historical return fluctuations p.a.

Fees and Expenses

Fees and Expenses

Fees and ExpensesTotal Management FeeÅOP (Costs)Indirect Trade Cost SubscriptionRedemption
Global Value Equities EUR Acc1.21 %2.00 %0.05 %0.00 %0.00 %

Key Information

ISINDK0060647600
Active Share81.0
Tracking Error-
Deviation + (1 year)-
Deviation + (3 years)-
Danish VP Code6064760
Sharpe Ratio (3 Years)-
NAV ultimo 201715.11 EUR
Year to Date1,67 %
Inception of Share Class21.09.2015
Tax Rate-
BenchmarkMSCI All Country World
ListedNo
AccumulatedYes
Share Class Assets (m) 22 EUR
Total Assets (m)97 EUR
Denomination10
Base currencyEUR
AGM (annual general meeting)04.04.2019
Dividend (2017)-
TER (incl. depositary and adm.exp)1,21 %
ÅOP (Costs)2 %
Indirect Trade Cost 0.05 %
Expected return p.a.7,00 % p.a.
Expected min. return, 1 year-11,00 %
Expected max return, 1 year25,00 %
Fund Holdings191
Rec. investment horizonMin. 4 years
Portfolio ManagerM. Thomassen & R. Narusis
NAV ultimo November 201815.36